Objective:Limited effective interventions for advanced hepatocellular carcinoma(HCC)are available.This study aimed to investigate the potential clinical utility of apatinib,a highly selective inhibitor of the vascular...Objective:Limited effective interventions for advanced hepatocellular carcinoma(HCC)are available.This study aimed to investigate the potential clinical utility of apatinib,a highly selective inhibitor of the vascular endothelial growth factor receptor-2(VEGFR2)tyrosine kinase,as a radiosensitizer in the treatment of HCC.展开更多
文摘Objective:Limited effective interventions for advanced hepatocellular carcinoma(HCC)are available.This study aimed to investigate the potential clinical utility of apatinib,a highly selective inhibitor of the vascular endothelial growth factor receptor-2(VEGFR2)tyrosine kinase,as a radiosensitizer in the treatment of HCC.